The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study
Authors
Keywords
-
Journal
EUROPEAN RADIOLOGY
Volume 21, Issue 2, Pages 281-290
Publisher
Springer Nature
Online
2010-08-04
DOI
10.1007/s00330-010-1914-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
- (2015) Anwar R. Padhani et al. NEOPLASIA
- Imagerie par résonance magnétique de diffusion (IRMD) en pathologie hépatique : principe et applications cliniques
- (2010) M. Lewin et al. JOURNAL DE RADIOLOGIE
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver
- (2009) Lorenzo Mannelli et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Diffusion-Weighted MRI of Advanced Hepatocellular Carcinoma During Sorafenib Treatment: Initial Results
- (2009) Christina Schraml et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
- (2009) Marius Horger et al. BMC CANCER
- Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
- (2009) Alejandro Forner et al. CANCER
- Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial
- (2009) Dow-Mu Koh et al. EUROPEAN RADIOLOGY
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Unresectable Hepatocellular Carcinoma: Serial Early Vascular and Cellular Changes after Transarterial Chemoembolization as Detected with MR Imaging
- (2009) Ihab R. Kamel et al. RADIOLOGY
- Diffusion-weighted MR Imaging of the Liver
- (2009) Bachir Taouli et al. RADIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Clinical significance of -fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma
- (2008) Noboru Mitsuhashi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging
- (2008) Tejas Parikh et al. RADIOLOGY
- Liver Cirrhosis: Intravoxel Incoherent Motion MR Imaging—Pilot Study
- (2008) Alain Luciani et al. RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started